Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)

Summary

The Deep and Frequent Phenotyping Study aims to discover new ways of diagnosing dementia, ideally decades before the symptoms become apparent in order to give future drug treatments the best chance of working.

The Deep and Frequent Phenotyping Study (DFP) will use big-data mathematical analyses to determine which tests, or combination of tests, might best predict the onset of Alzheimer’s Disease. This project was first announced around one year ago, and work is now about to start. Example of the tests to be considered include regular brain scans, cognitive and memory testing, retinal imaging, blood tests and applications of wearable technology to measure imperceptible changes to movement and gait.

“The Deep and Frequent Phenotyping Study, involving eight UK universities and the Alzheimer’s Society, and led by Prof Simon Lovestone at the University of Oxford, will aim to find the very earliest signs of Alzheimer’s, between 10 and 20 years before the symptoms become more obvious”.

Full Text Link

Reference

Bomford, A. (2017). Spotting the earliest signs of Alzheimer’s. London: BBC Health News, June 26th 2017.

Recent coverage by BBC Radio 4’s World At One programme:

Full Text / Audio Link

Reference

Bomford, A. (2017). How close are we to effectively treating Alzheimer’s? London: BBC Radio 4’s World At One, June 27th 2017.

Further detail is available here:

Full Text Link

Reference

Deep and Frequent Phenotyping; combinatorial biomarkers for dementia experimental medicine. [Online]: Gateway to Research (GtR), May 23rd 2017.

There is also a poster abstract, which mentions some earlier references:

Full Text Link

Reference

Abbott, R. Lovestone, S. [and] Lawson, J. [et al] on behalf of the DFP Study Team (2017). The Deep and Frequent Phenotyping (DFP) CANTAB cognitive assessment from the feasibility study.

Possibly of interest:

Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).

Reference

Nathan, PJ. Lim, YY. [and] Abbott, R. [et al]; PharmaCog Consortium. (2017). Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI). Neurobiology of Aging. May 2017; 53: 1-10.

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Alzheimer's Society, BBC News, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Mental Health, Models of Dementia Care, National, NIHR, Quick Insights, UK, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s